Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-066459
Filing Date
2008-11-24
Accepted
2008-11-24 16:51:02
Documents
1
Period of Report
2008-11-20

Document Format Files

Seq Description Document Type Size
1 form418643_112408165049-.html 4  
1 form418643_112408165049-.xml 4 10361
  Complete submission text file 0001144204-08-066459.txt   13455
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE NEW YORK NY 10021
Business Address TISCH FAMILY INTERESTS 667 MADISON AVENUE NEW YORK NY 10021 212-339-5600
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 081210976

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE NEW YORK NY 10021
Business Address TISCH FAMILY INTERESTS 667 MADISON AVENUE NEW YORK NY 10021 212-339-5600
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 081210978

Mailing Address 667 MADISON AVE 17TH FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE 17TH FLOOR NEW YORK NY 10065 212-339-5600
Baker Biotech Capital (GP), LLC (Reporting) CIK: 0001244389 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 081210977